End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
114.1 CNY | -1.75% | -7.79% | -9.38% |
Apr. 22 | Anhui Huaheng Biotechnology's Q1 Profit Jumps 7% | MT |
Apr. 22 | Anhui Huaheng Biotechnology's 2023 Profit Jumps 40% | MT |
Sales 2024 * | 3.17B 439M | Sales 2025 * | 4.1B 568M | Capitalization | 17.92B 2.48B |
---|---|---|---|---|---|
Net income 2024 * | 633M 87.6M | Net income 2025 * | 839M 116M | EV / Sales 2024 * | 5.86 x |
Net Debt 2024 * | 664M 91.88M | Net Debt 2025 * | 312M 43.23M | EV / Sales 2025 * | 4.44 x |
P/E ratio 2024 * |
28.4
x | P/E ratio 2025 * |
21.4
x | Employees | - |
Yield 2024 * |
1.09% | Yield 2025 * |
1.33% | Free-Float | 55.99% |
1 day | -1.75% | ||
1 week | -7.79% | ||
Current month | -3.66% | ||
1 month | +3.78% | ||
3 months | -1.96% | ||
6 months | +6.33% | ||
Current year | -9.38% |
Managers | Title | Age | Since |
---|---|---|---|
Geng Hua Guo
CEO | Chief Executive Officer | 60 | 05-04-12 |
Yi Fan
DFI | Director of Finance/CFO | 47 | 15-12-31 |
Xue Li Zhang
CTO | Chief Tech/Sci/R&D Officer | 43 | 13-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qi Feng Zhang
BRD | Director/Board Member | 51 | 19-07-31 |
Lin Wu
BRD | Director/Board Member | 65 | 22-06-27 |
Geng Hua Guo
CEO | Chief Executive Officer | 60 | 05-04-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +4.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 114.1 | -1.75% | 1,184,812 |
24-05-15 | 116.1 | -2.63% | 1,396,254 |
24-05-14 | 119.3 | +0.40% | 1,178,450 |
24-05-13 | 118.8 | -1.82% | 1,749,439 |
24-05-10 | 121 | -2.22% | 1,664,387 |
End-of-day quote Shanghai S.E., May 15, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.38% | 2.48B | |
-1.19% | 28.85B | |
+20.82% | 24.98B | |
+4.67% | 11.04B | |
+17.59% | 4.44B | |
-8.90% | 3.81B | |
+1.75% | 3.38B | |
+0.07% | 2.99B | |
+25.54% | 2.78B | |
+0.12% | 2.3B |
- Stock Market
- Equities
- 688639 Stock